vs
Side-by-side financial comparison of Orchid Island Capital, Inc. (ORC) and RxSight, Inc. (RXST). Click either name above to swap in a different company.
Orchid Island Capital, Inc. is the larger business by last-quarter revenue ($38.5M vs $32.6M, roughly 1.2× RxSight, Inc.). Orchid Island Capital, Inc. runs the higher net margin — 268.7% vs -28.1%, a 296.8% gap on every dollar of revenue. On growth, Orchid Island Capital, Inc. posted the faster year-over-year revenue change (372.6% vs -18.9%). Over the past eight quarters, Orchid Island Capital, Inc.'s revenue compounded faster (301.6% CAGR vs 5.1%).
Orchid Island Capital, Inc. is a U.S.-based specialty finance company operating as a real estate investment trust. It primarily invests in residential mortgage-backed securities, including agency and non-agency products, targeting consistent risk-adjusted returns for its investors across U.S. fixed income markets.
RxSight, Inc. is a medical technology company focused on developing and commercializing innovative intraocular lens solutions for patients undergoing cataract and refractive lens exchange procedures. Its flagship Light Adjustable Lens allows post-surgery power adjustment via a dedicated light delivery device, serving global ophthalmology care markets to improve post-operative visual outcomes for patients.
ORC vs RXST — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $38.5M | $32.6M |
| Net Profit | $103.4M | $-9.2M |
| Gross Margin | — | 77.5% |
| Operating Margin | — | -34.8% |
| Net Margin | 268.7% | -28.1% |
| Revenue YoY | 372.6% | -18.9% |
| Net Profit YoY | 1764.9% | -54.1% |
| EPS (diluted) | — | $-0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $38.5M | $32.6M | ||
| Q3 25 | $26.9M | $30.3M | ||
| Q2 25 | $23.2M | $33.6M | ||
| Q1 25 | $19.7M | $37.9M | ||
| Q4 24 | — | $40.2M | ||
| Q3 24 | $340.0K | $35.3M | ||
| Q2 24 | $-697.0K | $34.9M | ||
| Q1 24 | $-2.5M | $29.5M |
| Q4 25 | $103.4M | $-9.2M | ||
| Q3 25 | $72.1M | $-9.8M | ||
| Q2 25 | $-33.6M | $-11.8M | ||
| Q1 25 | $17.1M | $-8.2M | ||
| Q4 24 | — | $-5.9M | ||
| Q3 24 | $17.3M | $-6.3M | ||
| Q2 24 | $-5.0M | $-6.1M | ||
| Q1 24 | $19.8M | $-9.1M |
| Q4 25 | — | 77.5% | ||
| Q3 25 | — | 79.9% | ||
| Q2 25 | — | 74.9% | ||
| Q1 25 | — | 74.8% | ||
| Q4 24 | — | 71.6% | ||
| Q3 24 | — | 71.4% | ||
| Q2 24 | — | 69.5% | ||
| Q1 24 | — | 70.1% |
| Q4 25 | — | -34.8% | ||
| Q3 25 | — | -40.1% | ||
| Q2 25 | — | -41.6% | ||
| Q1 25 | — | -28.2% | ||
| Q4 24 | — | -21.5% | ||
| Q3 24 | — | -26.1% | ||
| Q2 24 | — | -23.9% | ||
| Q1 24 | — | -36.2% |
| Q4 25 | 268.7% | -28.1% | ||
| Q3 25 | 267.8% | -32.4% | ||
| Q2 25 | -145.0% | -35.0% | ||
| Q1 25 | 86.9% | -21.6% | ||
| Q4 24 | — | -14.8% | ||
| Q3 24 | 5094.1% | -17.9% | ||
| Q2 24 | 714.3% | -17.4% | ||
| Q1 24 | -794.2% | -30.8% |
| Q4 25 | — | $-0.22 | ||
| Q3 25 | — | $-0.24 | ||
| Q2 25 | — | $-0.29 | ||
| Q1 25 | — | $-0.20 | ||
| Q4 24 | — | $-0.14 | ||
| Q3 24 | — | $-0.16 | ||
| Q2 24 | — | $-0.16 | ||
| Q1 24 | — | $-0.25 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $665.9M | $228.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.4B | $275.7M |
| Total Assets | $11.7B | $311.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $665.9M | $228.1M | ||
| Q3 25 | $583.9M | $227.5M | ||
| Q2 25 | $440.8M | $227.5M | ||
| Q1 25 | $396.4M | $229.3M | ||
| Q4 24 | — | $237.2M | ||
| Q3 24 | $322.1M | $237.1M | ||
| Q2 24 | $241.0M | $233.3M | ||
| Q1 24 | $190.4M | $125.4M |
| Q4 25 | $1.4B | $275.7M | ||
| Q3 25 | $1.1B | $276.0M | ||
| Q2 25 | $912.0M | $278.0M | ||
| Q1 25 | $855.9M | $279.3M | ||
| Q4 24 | — | $281.2M | ||
| Q3 24 | $656.0M | $277.3M | ||
| Q2 24 | $555.9M | $275.2M | ||
| Q1 24 | $481.6M | $163.9M |
| Q4 25 | $11.7B | $311.8M | ||
| Q3 25 | $9.1B | $308.5M | ||
| Q2 25 | $7.6B | $309.0M | ||
| Q1 25 | $7.3B | $313.0M | ||
| Q4 24 | — | $318.6M | ||
| Q3 24 | $5.9B | $310.5M | ||
| Q2 24 | $4.9B | $305.5M | ||
| Q1 24 | $4.2B | $183.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $120.4M | $-1.1M |
| Free Cash FlowOCF − Capex | — | $-2.3M |
| FCF MarginFCF / Revenue | — | -6.9% |
| Capex IntensityCapex / Revenue | — | 3.5% |
| Cash ConversionOCF / Net Profit | 1.16× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-19.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $120.4M | $-1.1M | ||
| Q3 25 | $28.0M | $-1.2M | ||
| Q2 25 | $18.4M | $-4.4M | ||
| Q1 25 | $25.8M | $-8.8M | ||
| Q4 24 | — | $-4.3M | ||
| Q3 24 | $-14.8M | $650.0K | ||
| Q2 24 | $19.3M | $-4.0M | ||
| Q1 24 | $45.0M | $-9.3M |
| Q4 25 | — | $-2.3M | ||
| Q3 25 | — | $-1.8M | ||
| Q2 25 | — | $-5.9M | ||
| Q1 25 | — | $-9.4M | ||
| Q4 24 | — | $-5.1M | ||
| Q3 24 | — | $-453.0K | ||
| Q2 24 | — | $-5.5M | ||
| Q1 24 | — | $-11.3M |
| Q4 25 | — | -6.9% | ||
| Q3 25 | — | -5.8% | ||
| Q2 25 | — | -17.6% | ||
| Q1 25 | — | -24.8% | ||
| Q4 24 | — | -12.7% | ||
| Q3 24 | — | -1.3% | ||
| Q2 24 | — | -15.9% | ||
| Q1 24 | — | -38.2% |
| Q4 25 | — | 3.5% | ||
| Q3 25 | — | 1.9% | ||
| Q2 25 | — | 4.6% | ||
| Q1 25 | — | 1.5% | ||
| Q4 24 | — | 2.1% | ||
| Q3 24 | — | 3.1% | ||
| Q2 24 | — | 4.4% | ||
| Q1 24 | — | 6.7% |
| Q4 25 | 1.16× | — | ||
| Q3 25 | 0.39× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 1.51× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -0.86× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 2.28× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ORC
Segment breakdown not available.
RXST
| Rxlal | $28.2M | 86% |
| LDD | $3.0M | 9% |
| Service Warranty Service Contracts And Accessories | $1.5M | 4% |
